Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Mastrokolias, Anastasios ^a   den Dunnen, Johan T ^a   van Ommen, GertJan B ^a   't Hoen, Peter A C ^a   van Roon Mom, Willeke M C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLOBIN; OLIGONUCLEOTIDE; RNA;

ADULT; AGED; ARTICLE; BIOTYPE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE SEQUENCE; GLOBIN SYNTHESIS; HUMAN; MALE; POSTTRANSCRIPTIONAL GENE SILENCING; RELIABILITY; SENSITIVITY ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

ADULT; AGED; FEMALE; GENE EXPRESSION PROFILING; GLOBINS; HUMANS; MALE; MIDDLE AGED; RNA; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION;

EID: 84855893655     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-28     Document Type: Article

References (31)

1. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009, 14:156-174. 10.1038/mp.2008.11, 18301394.
2. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008, 26:1135-1145. 10.1038/nbt1486, 18846087.
3. Nielsen KL, Hogh AL, Emmersen J. DeepSAGE digital transcriptomics with high sensitivity, simple experimental protocol and multiplexing of samples. Nucleic Acids Res 2006, 34:e133. 10.1093/nar/gkl714, 1636492, 17028099.
4. Feng L, Liu H, Liu Y, Lu Z, Guo G, Guo S, et al. Power of deep sequencing and agilent microarray for gene expression profiling study. Mol Biotechnol 2010, 45:101-110. 10.1007/s12033-010-9249-6, 20432071.
5. van Iterson M, 't Hoen PA, Pedotti P, Hooiveld GJ, Den Dunnen JT, Van Ommen GJ, et al. Relative power and sample size analysis on gene expression profiling data. BMC Genomics 2009, 10:439. 10.1186/1471-2164-10-439, 2759969, 19758461.
6. 't Hoen PA, Ariyurek Y, Thygesen HH, Vreugdenhil E, Vossen RH, de Menezes RX, et al. Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res 2008,
7. Pahl A. Gene expression profiling using RNA extracted from whole blood: technologies and clinical applications. Expert Rev Mol Diagn 2005, 5:43-52. 10.1586/14737159.5.1.43, 15723591.
8. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004, 350:1617-1628. 10.1056/NEJMoa040465, 15084694.
9. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. PNAS 2005, 102:11023-11028. 10.1073/pnas.0504921102, 1182457, 16043692.
10. Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:261-268. 10.1002/ajmg.b.30272, 16526044.
11. Dudley JT, Tibshirani R, Deshpande T, Butte AJ. Disease signatures are robust across tissues and experiments. Mol Syst Biol 2009, 5:307. 2758720, 19756046.
12. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006, 147:126-132. 10.1016/j.lab.2005.10.005, 16503242.
13. Muller MC, Merx K, Weisser A, Kreil S, Lahaye T, Hehlmann R, et al. Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization. Leukemia 2002, 16:2395-2399. 10.1038/sj.leu.2402734, 12454744.
14. Debey S, Schoenbeck U, Hellmich M, Gathof BS, Pillai R, Zander T, et al. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 2004, 4:193-207. 10.1038/sj.tpj.6500240, 15037859.
15. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002, 48:1883-1890.
16. Ovstebo R, Lande K, Kierulf P, Haug KB. Quantification of relative changes in specific mRNAs from frozen whole blood - methodological considerations and clinical implications. Clin Chem Lab Med 2007, 45:171-176. 10.1515/CCLM.2007.035, 17311503.
17. Field LA, Jordan RM, Hadix JA, Dunn MA, Shriver CD, Ellsworth RE, et al. Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples. Clin Biochem 2007, 40:499-502. 10.1016/j.clinbiochem.2007.01.004, 17303101.
18. Vartanian K, Slottke R, Johnstone T, Casale A, Planck SR, Choi D, et al. Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics 2009, 10:2. 10.1186/1471-2164-10-2, 2649161, 19123946.
19. Wright C, Bergstrom D, Dai HY, Marton M, Morris M, Tokiwa G, et al. Characterization of globin RNA interference in gene expression profiling of whole-blood samples. Clin Chem 2008, 54:396-405. 10.1373/clinchem.2007.093419, 18089658.
20. Tian Z, Palmer N, Schmid P, Yao H, Galdzicki M, Berger B, et al. A Practical Platform for Blood Biomarker Study by Using Global Gene Expression Profiling of Peripheral Whole Blood. PLoS ONE 2009, 4.
21. Debey S, Zander T, Brors B, Popov A, Eils R, Schultze JL. A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics 2006, 87:653-664. 10.1016/j.ygeno.2005.11.010, 16387473.
22. Bogdanova EA, Shagin DA, Lukyanov SA. Normalization of full-length enriched cDNA. Mol Biosyst 2008, 4:205-212. 10.1039/b715110c, 18437263.
23. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517. 10.1261/rna.5248604, 1370637, 15383676.
24. Huang D, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
25. Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945. 10.1038/nature03001, 15496913, Human Genome Sequencing Consortium.
26. Wright MW, Bruford EA. Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics 2011, 5:90-98. 3051107, 21296742.
27. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol 2010, 220:126-139. 10.1002/path.2638, 19882673.
28. Liu J, Walter E, Stenger D, Thach D. Effects of globin mRNA reduction methods on gene expression profiles from whole blood. J Mol Diagn 2006, 8:551-558. 10.2353/jmoldx.2006.060021, 1876175, 17065423.
29. Ruijter JM, Ramakers C, Hoogaars WMH, Karlen Y, Bakker O, van den Hoff MJB, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Research 2009, 37.
30. Robinson MD, Smyth GK. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 2008, 9:321-332.
31. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010, 26:139-140. 10.1093/bioinformatics/btp616, 2796818, 19910308.